ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 182 filers reported holding ACORDA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 4.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $8,046,000 | -29.7% | 428,000 | -21.9% | 1.90% | -48.2% |
| Q3 2016 | $11,442,000 | +93.4% | 548,000 | +136.2% | 3.67% | +63.0% |
| Q2 2016 | $5,917,000 | -37.5% | 232,000 | -35.2% | 2.25% | -39.4% |
| Q1 2016 | $9,469,000 | +0.6% | 358,000 | +62.7% | 3.72% | +10.7% |
| Q4 2015 | $9,412,000 | -15.1% | 220,000 | -47.4% | 3.36% | -11.2% |
| Q3 2015 | $11,081,000 | +78.8% | 418,000 | +124.7% | 3.78% | +69.9% |
| Q2 2015 | $6,199,000 | – | 186,000 | – | 2.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |